How ‘Pay to Delay’ Impacts Self-Insureds and Other Pharmaceutical Payers
Risk & Insurance - Sep 16, 2020
Two parallel courses of litigation, one in California and one in Illinois, have thrust the long-running dispute over the high cost of patented pharmaceuticals to the fore. Advertisement They have also reinforced how complex the issues are. Late in July, the U.S. Ninth Circuit Court upheld Califo...
Recommended Articles
Posted: Apr 13, 2026
Invisible chronic conditions often cause workplace injuries, requiring proactive data-driven support...
Posted: Apr 12, 2026
We've established resilience as important. Now we need to embed it more deeply into day-to-day opera...
Posted: Apr 10, 2026
The latest people news in the industry today. The post Jesse F. Gutierrez Promoted to Divisional Pre...